Literature DB >> 3038917

Peripheral effects of neurokinins: functional evidence for the existence of multiple receptors.

C A Maggi, S Giuliani, P Santicioli, D Regoli, A Meli.   

Abstract

The ability of six neurokinins (substance P, neurokinin A, neurokinin B, physalaemin, eledoisin and kassinin) to induce hypotension, salivary secretion and to activate motility of the duodenum and of the urinary bladder was investigated in urethane-anaesthetized rats. A comparison of the relative potency of these substances in producing a given biological effect yielded results consistent with the hypothesis of the existence of three distinct types of receptor in rat peripheral tissues, namely SP-P, SP-K and SP-E according to the nomenclature proposed by Buck, Burcher, Shults, Lovenberg & O'Donohue (1984), or NK-P, NK-A and NK-B according to that of Regoli, D'Orleans-Juste, Drapeau, Dion & Escher (1985). An NK-P receptor is responsible for the production of the hypotensive effect and for the activation of salivary secretion. An 'NK-P like' receptor subtype may be involved in determining the direct contractile effects on muscle cells of neurokinins in the rat isolated urinary bladder and the 'phasic' contraction of the rat duodenum. An NK-A receptor mediates the 'tonic' contraction of the rat duodenum while an NK-B receptor mediates the activation of the micturition reflex. Evidence is presented that multiple neurokinin receptors are present in the same organ and participate with different modalities to the regulation of smooth muscle function.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3038917     DOI: 10.1111/j.1474-8673.1987.tb00130.x

Source DB:  PubMed          Journal:  J Auton Pharmacol        ISSN: 0144-1795


  9 in total

1.  The non-peptide tachykinin antagonist, CP-96,345, is a potent inhibitor of neurogenic inflammation.

Authors:  F Lembeck; J Donnerer; M Tsuchiya; A Nagahisa
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

2.  Further evidence for the existence of NK2 tachykinin receptor subtypes.

Authors:  R Patacchini; M Astolfi; L Quartara; P Rovero; A Giachetti; C A Maggi
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

3.  Pharmacological profile of the novel mammalian tachykinin, hemokinin 1.

Authors:  Francesca Bellucci; Francesca Carini; Claudio Catalani; Paola Cucchi; Alessandro Lecci; Stefania Meini; Riccardo Patacchini; Laura Quartara; Renzo Ricci; Manuela Tramontana; Sandro Giuliani; Carlo Alberto Maggi
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

4.  Effect of CP-96,345, a nonpeptide substance P receptor antagonist, on salivation in rats.

Authors:  R M Snider; K P Longo; S E Drozda; J A Lowe; S E Leeman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

5.  Competitive antagonists discriminate between NK2 tachykinin receptor subtypes.

Authors:  C A Maggi; R Patacchini; S Giuliani; P Rovero; S Dion; D Regoli; A Giachetti; A Meli
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

6.  Neurogenic plasma leakage in mouse airways.

Authors:  P Baluk; G Thurston; T J Murphy; N W Bunnett; D M McDonald
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

7.  FR 113680: a novel tripeptide substance P antagonist with NK1 receptor selectivity.

Authors:  H Morimoto; M Murai; Y Maeda; D Hagiwara; H Miyake; M Matsuo; T Fujii
Journal:  Br J Pharmacol       Date:  1992-05       Impact factor: 8.739

8.  A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder.

Authors:  J M Hall; J M Flowers; I K Morton
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

9.  Characterization of the peripheral action of neurokinins and neurokinin receptor selective agonists on the rat cardiovascular system.

Authors:  R Couture; O Laneuville; C Guimond; G Drapeau; D Regoli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-11       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.